Walter E. Washington Convention Center
Washington, D.C.
May 16-19, 2022

Wacker Biotech

San Diego,  CA 
United States
  • Booth: 254

Wacker Biotech is “THE MICROBIAL CDMO” – your partner of choice for process development and commercial manufacturing of biopharmaceuticals (proteins, vaccines, live microbial products, and plasmid DNA (pDNA)) using microbial hosts. Developed over decades, our plug-and-play platform for pDNA is suitable for manufacturing R&D supplies (non-GMP) up to scale-up to full GMP-compliant production. Our integrated service portfolio covers molecular biology, process- and analytical development as well as GMP manufacturing of biologics for clinical and commercial supply. 


    WACKER BIOTECH is your partner of choice for process development and contract manufacturing of biopharmaceuticals including recombinant proteins, vaccines, live microbial products and plasmid DNA using microbial hosts....

  • WACKER BIOTECH operates four state-of-the-art GMP facilities located in the U.S., Germany and The Netherlands. Manufacturing lines are equipped with stainless steel fermentation vessels from 350 to 1500 liter as well as single-use bioreactors. Matching primary recovery, downstream and Fill & Finish capabilities are available to suit various clients’ needs across the development path (BSL 1 and 2). Additionally, a GMP cell-bank suite enables independent cell-bank production and storage capacity for client cell banks.

    Wacker Biotech offers capacities for pDNA GMP manufacturing ranging up to 500 L stainless steel fermenters. Fermentation, downstream purification including continuous lysis, and pDNA quality control are part of our proprietary platform. A highly experienced, specialized team provides products and services that meet the highest quality and compliance standards.